药用大麻提取物在体外对Aβ1-42介导的毒性有神经保护作用
Dylan T Marsh1, Mayu Shibuta2, Ryuji Kato2,3,4
1Discipline of Pharmacology, School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
Basic & clinical pharmacology & toxicology
|September 7, 2024
概括
富含四大麻素 (THC) 和四大麻酸 (THCA) 的医用大麻提取物显示出对阿尔茨海默氏症蛋白质聚合的神经保护. 这些发现可能会指导未来的医学大麻治疗痴呆症.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样β (Aβ) 蛋白聚合和神经毒性.
- 植物性大麻素,大麻中发现的化合物,已经显示出抑制Aβ聚合和神经毒性的潜力.
研究的目的:
- 评估五种专有医用大麻提取物对Aβ诱导的神经毒性和脂质过氧化的神经保护能力.
- 描述不同比例的大麻 (CBD) 和Δ9-四大麻 (THC),包括它们的碳化形式,对神经保护的影响.
主要方法:
- 在PC12细胞中使用 thiazolyl blue tetrazolium bromide (MTT) 试验来评估神经保护.
- 使用传输电子显微镜和光显微镜可视化Aβ聚合和植物性大麻素相互作用.
主要成果:
- THC/THCA 主导的提取物表现出显著的神经保护,防止Aβ1-42诱导的PC12细胞死亡,即使在加热后.
- 没有任何提取物能对脂质过氧化产生显著的保护.
- 非加热的BC-401提取物显示了Aβ1-42聚合的适度抑制,但没有发现聚合抑制和神经保护之间的明显相关性.
结论:
- 含有THC/THCA和CBD/CBDA的大麻提取物对Aβ神经毒性和聚合具有可变的神经保护作用.
- 研究结果表明,特定的医用大麻配方在治疗阿尔茨海默氏症和痴呆症方面具有潜力.
相关概念视频
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...


